The goal of this project is to define the regulatory aspects of the human T cell response to alloantigens. There is need for a more precise approach to therapy, based upon promotion of antigen- specific suppressor responses, while inhibiting effector responses which injure graft tissues. Little is known about the antigen specificity of allo-suppressor cells, or the circuitry of cell-cell interactions. Preliminary results with HLA defined reference panel members and MLR-induced suppressor cells demonstrate a weak correlation for specificity of suppression with the known HLA antigens, consistent with the hypothesis that there could be polymorphic regions of Class I and Class II molecules unique for suppressor T cell receptors. An extensive panel of HLA homozygous lymphoblastoid cell lines will be used to explore this hypothesis in detail. There is considerable evidence for a continuing active immune response in successfully grated drug-suppressed patients, but studies to date using classic definitions of CD4 and CD8 populations, those which relate to specific functional programs in antigen and mitogen stimulation will be extensively employed for in vitro manipulations, and in serial analysis in transplant patients. For example, monoclonal antibody 2H4 reacts with an epitope on the leucocyte common antigen (LCA) T200 family of molecules and marks the inducer of suppression within CD4, while the inducers of B cell help or cytotoxic cells are 2H4-. S6F1 marks an epitope found on a subset of LFA-1 molecules present on mature cytotoxic, but not suppressor, cells. The possibility that minor populations of T cells of unusual phenotype may play a role in alloresponses will also be explored. Preliminary study of blood and graft infiltrates from transplanted patients has revealed doubly positive CD4+CD8+ T cells. In addition, T cells bearing gamma-delta antigen receptor heterodimers, instead of the predominant alpha-beta TCR (T3-Ti) are found in increased numbers in blood and grafts of some patients, and can be cloned. Both of these newly appreciated subsets are of unknown function. This project will interact directly with Project 2 on development and molecular studies of monoclonal antibodies, and with in vivo protocols in the primate transplant Project 3.

Project Start
Project End
Budget Start
Budget End
Support Year
5
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02115
Duke-Cohan, J S; Morimoto, C; Rocker, J A et al. (1996) Serum high molecular weight dipeptidyl peptidase IV (CD26) is similar to a novel antigen DPPT-L released from activated T cells. J Immunol 156:1714-21
Duke-Cohan, J S; Morimoto, C; Rocker, J A et al. (1995) A novel form of dipeptidylpeptidase IV found in human serum. Isolation, characterization, and comparison with T lymphocyte membrane dipeptidylpeptidase IV (CD26). J Biol Chem 270:14107-14
Martin-Reay, D G; Kamentsky, L A; Weinberg, D S et al. (1994) Evaluation of a new slide-based laser scanning cytometer for DNA analysis of tumors. Comparison with flow cytometry and image analysis. Am J Clin Pathol 102:432-8
Dawson, A E; Cibas, E S; Bacus, J W et al. (1993) Chromatin texture measurement by Markovian analysis. Use of nuclear models to define and select texture features. Anal Quant Cytol Histol 15:227-35
Araten, D J; Lawton, T; Ferrara, J et al. (1993) In vitro alloreactivity against host antigens in an adult HLA-mismatched bone marrow transplant recipient despite in vivo host tolerance. Transplantation 55:76-82
Sayegh, M H; Khoury, S J; Hancock, W W et al. (1993) Induction of immunity and oral tolerance to alloantigen by polymorphic class II major histocompatibility complex allopeptides in the rat. Transplant Proc 25:357-8
Weinberg, D S; Weidner, N (1993) Concordance of DNA content between prostatic intraepithelial neoplasia and concomitant invasive carcinoma. Evidence that prostatic intraepithelial neoplasia is a precursor of invasive prostatic carcinoma. Arch Pathol Lab Med 117:1132-7
Duke-Cohan, J S; Morimoto, C; Schlossman, S F (1993) Targeting of an activated T-cell subset using a bispecific antibody-toxin conjugate directed against CD4 and CD26. Blood 82:2224-34
Duke-Cohan, J S; Morimoto, C; Schlossman, S F (1993) Depletion of the helper/inducer (memory) T cell subset using a bispecific antibody-toxin conjugate directed against CD4 and CD29. Transplantation 56:1188-96
Hancock, W W; Sayegh, M H; Kwok, C A et al. (1993) Oral, but not intravenous, alloantigen prevents accelerated allograft rejection by selective intragraft Th2 cell activation. Transplantation 55:1112-8

Showing the most recent 10 out of 30 publications